⌘K

Home/Filings/4/0001415889-22-012767

4//SEC Filing

Atadja Peter 4

Accession 0001415889-22-012767

CIK 0001130598other

View on SEC.gov Company Profile

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 6:56 PM ET

Size

5.4 KB

Accession

0001415889-22-012767

Insider Transaction Report

Form 4

Period: 2022-12-15

Onconova Therapeutics, Inc.ONTX

Director

Transactions

Award
Stock Option (right to purchase)
2022-12-15+100,000→ 100,000 total
Exercise: $0.71Exp: 2032-12-15→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]These options vest in 3 installments on the anniversary of the grant date: 33% on the first anniversary, 33% on the second anniversary and 34% on the third anniversary.

Documents

1 file

4
form4-12192022_111223.xmlPrimary

Issuer

Onconova Therapeutics, Inc.

CIK 0001130598

Entity typeother

Related Parties

1

filerCIK 0001958563

Filing Metadata

Form type: 4
Filed: Dec 18, 7:00 PM ET
Accepted: Dec 19, 6:56 PM ET
Size: 5.4 KB

View on SEC.gov